Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Public sector seeks to bridge 'valley of death'

Article Abstract:

The U.S., Europe and Australia are increasing their support for translational research, drug design and discovery. The U.S. National Cancer Institute's Rapid Access to Interventional Development (RAID) program, the National Institutes of Health (NIH) the U.K.'s Medical Research Council (MRC) are some of the organizations that are providing funds for the drug discovery, research and development.

Author: Moran, Naula
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Public affairs, Social aspects, Analysis, Public sector, Federal aid to medical research, Medical research assistance

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A change in the market - investing in diagnostics

Article Abstract:

Investors do not find the diagnostic market attractive due to low margins, tricky reimbursement issues and the difficulty of market penetration. Factors like changes in healthcare economics, regulation and the adoption to companion diagnostic tests, which are predictive for drug response, are expected to change the perceptive.

Author: Miller, Peter, Batchelder, Keith
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
United States, Forecasts, trends, outlooks, HEALTH SERVICES, Economic aspects, Health care industry, Industry forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Finance, Company financing
Similar abstracts:
  • Abstracts: The dynamics of price elasticity of demand in the presence of reference price effects. Not telling the whole story: Teen deception in purchasing
  • Abstracts: Competition in local-service sectors. Virtual Bass model and the left-hand data-truncation bias in diffusion of innovation studies
  • Abstracts: Assessing the use of derivatives as part of a risk-management strategy. Operating performance following open market share repurchase announcements
  • Abstracts: Managing your compensation expectations in today's environment: a second look
  • Abstracts: Restored credibility for sepsis therapeutics? Do targets limit antibiotic discovery? Rapid-response vaccines: Does DNA offer a solution?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.